Veraxa Biotech Holding AG (VRXA)
$1.20+5.26%Close
SELL
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $170M
- Beta
- 0.26
- Short % float
- 1.86%
- Days to cover
- 4.6
- SI change
- +12.1%
- 1W
- +11.11%
- 1M
- -26.38%
- vs SPY 1W
- +11.25%
- vs SPY 1M
- -28.89%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on VRXA?
- LOPJLB’s latest quantitative signal on Veraxa Biotech Holding AG (VRXA) is SELL. Signals are updated daily.
- What market regime is VRXA in?
- LOPJLB classifies each ticker into BULL, RECOVERY, BEAR, or CRISIS regimes using a Hidden Markov Model.
- What does Veraxa Biotech Holding AG (VRXA) do?
- Veraxa Biotech AG develops antibody-based therapeutics and antibody-drug conjugates for cancer treatment. The company develops antibody-based therapeutics, including antibody-drug conjugates and bispecific antibody formats, and offers a proprietary technology platform for functional antibody screening and bioconjugation. Its product pipeline includes drug candidates such as ADCs and BITACs, wit…